QCI Interpret for Oncology

Benefits of integrating targeted next-generation sequencing (NGS) panels into molecular diagnostics of solid tumors

139 views
July 18, 2024
Variant detection of multiple genes from a single tumor sample requires high-throughput molecular testing. To meet this demand, targeted next-generation sequencing (NGS) panels are useful in clinical settings for accurate tumor profiling and the identification of essential molecular aberrations for personalized therapies. By focusing only on a subset of genes, targeted NGS is not only a cost-effective solution, but can rapidly deliver insights into a tumor molecular profile.

To address this challenge, a clinical research team led by Dr. Michela Bulfoni at the Istituto di Anatomia Patologica designed custom NGS panels, named “Glioma” and “Routine Diagnostics”, targeting single nucleotide variations, insertions/deletions, fusions, and copy number variations of tumor-associated essential genes.

In this webinar, attendees will:
- Understand the clinical utility of custom-designed NGS panels for accurate tumour diagnosis
- Learn about the design and application of these NGS panels
- Gain insights into the cost-effectiveness and high sensitivity of NGS panels in improving sample throughput


Category: QCI Interpret for Oncology, Sample to Insight

Related videos

QCI Interpret for Oncology

FASTQ to final report: Ultra-fast workflow for CGP

430 views July 21, 2022

As our molecular knowledge of cancer continually evolves, a new era in cancer...

QCI Interpret for Oncology

Real-World Applications of Clinical Metagenomic Sequencing in Cancer and Infectious Disease...

384 views October 31, 2023

Clinical metagenomic next-generation sequencing (mNGS), the comprehensive...

QCI Interpret for Oncology

Clinician’s Roundtable: Interpreting genomic test results for precision oncology

341 views May 21, 2024

You’re invited to attend the 2024 Clinician’s Roundtable, a virtual event...

QCI Interpret for Oncology

Comprehensive Molecular Tumor Analysis with Alacris Theranostics

340 views March 09, 2023

Precision oncology approaches have made great strides harnessing individual...